Purchase Order 75N93023P00842

Award Date 7/24/23
Potential Completion Date 7/23/24
Potential Value $36K
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Carlsbad, CA 92008, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $24,842.16 contract is for the delivery of Value Hi Fetal Bovine Serum, a critical biological material used in biomedical research. Life Technologies Corporation, a division of the parent company Thermo Fisher...
This is a firm fixed price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $7,560.00 contract is for the delivery of fetal bovine serum, ultra-low IgG, of U.S. origin. The award does not utilize any set-aside designations. Life Technologies is a division of the parent company Thermo...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order contract to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables, for the delivery of US Certified Heat Inactivated Fetal Bovine Serum. The contract has a completion date of September 29, 2017, a potential value of $9,360.00, and did not utilize any set-aside designations. Life...
This is a $17,801.60 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific. The contract is for the delivery of fetal bovine serum, a critical reagent used in biomedical research. This award does not utilize any set-aside designations. Life Technologies Corporation has a history of serving as a...
This contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation (doing business as Thermo Fisher Scientific) for the supply of fetal bovine serum. The contract has a ceiling value of $18,173.60 and is a firm-fixed-price purchase order with a completion date of December 31, 2024. The contract does not utilize a set-aside designation. Life Technologies...
This federal contract award to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, is for the purchase of 100 units of USDA Qualified High Fetal Bovine Serum (500ml, Lot# 929426, Cat# 10438026) at a Firm Fixed Price of $100.00 per unit, for a total ceiling value of $10,017.50. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), and does not have a set-aside designation. As a prime...
This is a $11,760.00 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract is for the delivery of 120 bottles of US Qualified FBS (Fetal Bovine Serum) catalog number 26140079 at $98.00 per bottle. This contract does not have a set-aside designation. As a division of Thermo Fisher Scientific, Life Technologies has...
This is a $16,025.00 firm fixed-price purchase order awarded by the National Human Genome Research Institute, a civilian federal agency, to Global Life Sciences Solutions USA LLC, a for-profit limited liability company. The award is for the supply of 500 ml bottles of heat-inactivated fetal bovine serum, a common biological material used in biomedical research. The order has a completion date of December 31, 2024 and was not set aside for any specific business type. In addition to this...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Life Technologies Corporation, a division of Thermo Fisher Scientific, for the procurement of 500 mL bottles of US certified fetal bovine serum (FBS) with a catalog number of 16000044. The contract has a ceiling value of $30,712.50 and a period of performance ending on March 19, 2016. No set-aside designation was used for this award. As a prime contractor, Life...
This firm fixed price purchase order, valued at $37,114, was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Global Life Sciences Solutions USA LLC. The contract calls for the delivery of 100 units of Hyclone-Cytiva Fetal Bovine Serum at 500ml per unit to a location in Bethesda, Maryland. This matches the key requirements laid out in the original solicitation, which mandated the specific brand of FBS...

This firm fixed price purchase order was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Life Technologies Corporation for $35,692.80. The contract calls for Life Technologies to deliver 80 units of heat inactivated fetal bovine serum with lot number 2661794P to the NIH Clinical Center in Bethesda, Maryland. The serum will support ongoing cell culture work and clinical research being performed by the Laboratory of Immunoregulation's HIV Immunovirology Section regarding HIV pathogenesis and viral reservoirs. Specifically, the serum is required to culture CD4 and CD8+ T cells from clinical trials and studies examining immune control of HIV replication in the absence of antiretroviral drugs. Shipments of 20 bottles must be delivered on specified dates between August 2023 and June 2024. As the sole authorized distributor of the specified lot, Life Technologies was selected on a sole source basis according to FAR 13.106-1. No subcontractors or special designations were identified.

Generated 12/19/23, 9:16 PM